Analyst Price Targets — MDT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 11:19 am | Ryan Zimmerman | BTIG | $91.00 | $83.87 | TheFly | Medtronic price target raised to $91 from $90 at BTIG |
| July 6, 2026 12:44 pm | — | Evercore ISI | $105.00 | $81.61 | TheFly | Medtronic price target lowered to $105 from $106 at Evercore ISI |
| June 16, 2026 1:46 pm | Matt O'Brien | Piper Sandler | $85.00 | $81.15 | StreetInsider | Piper Sandler on Medtronic, Inc. (MDT): 'Warming to the Story but Not Quite There' |
| June 5, 2026 12:31 pm | David Roman | Goldman Sachs | $83.00 | $82.28 | TheFly | Medtronic price target lowered to $83 from $84 at Goldman Sachs |
| June 4, 2026 1:21 pm | — | Truist Financial | $86.00 | $81.64 | TheFly | Medtronic price target lowered to $86 from $95 at Truist |
| June 4, 2026 12:26 pm | Lee Hambright | Bernstein | $97.00 | $82.54 | StreetInsider | Medtronic, Inc. (MDT) PT Lowered to $97 at Bernstein SocGen Group |
| June 4, 2026 10:59 am | David Rescott | Robert W. Baird | $85.00 | $77.95 | TheFly | Medtronic price target lowered to $85 from $93 at Baird |
| June 4, 2026 10:15 am | Priya Sachdeva | UBS | $85.00 | $77.95 | TheFly | Medtronic price target lowered to $85 from $90 at UBS |
| June 4, 2026 8:12 am | Matthew Taylor | Jefferies | $88.00 | $77.95 | StreetInsider | Medtronic, Inc. (MDT) PT Lowered to $88 at Jefferies |
| June 3, 2026 8:12 pm | — | BTIG | $90.00 | $77.95 | TheFly | Medtronic upgraded to Buy at BTIG on consistent organic growth |
Latest News for MDT
Allspring Global Investments Holdings LLC cut its stake in Medtronic PLC (NYSE: MDT) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 885,098 shares of the medical technology company's stock after selling 178,782 shares during the quarter. Allspring Global
Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹ GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous…
Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.
Medtronic plc is rated buy with a $92 price target, reflecting conservative fiscal 2027 guidance and resilient growth platforms. Fiscal 2026 delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions outpacing market rates. Guidance for fiscal 2027 excludes potential catalysts—MiniMed separation, tariff refunds, and Blackstone payment relief—implying room for upside…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.